BULLETIN OF THE
Note
KOREAN CHEMICAL SOCIETY
the IMFC reaction of 7 gave 5a as the sole product (74%). The
corresponding Friedel–Crafts alkylation product was not
formed in the reaction, and the result showed that Friedel–
Crafts acylation is more effective than the alkylation with
the carboxylic acid derivative 7.
In summary, the first successful IMFC cyclization of N-
cinnamylisatin derivatives in PPA provided pyrrolo[3,2,1-ij]
quinoline-1,2-diones in good to moderate yields. The
electron-deficient benzene ring of isatin could be used effec-
tively in the IMFC reaction in PPA, although some restrictions
are still present.
139.44, 144.97, 156.13, 171.14, 182.07; ESIMS m/z
356 [M+ + H], 358 [M++H + 2].
Compound4d:42%; redsolid, m.p. 166–168 ꢀC;IR(KBr)
1739, 1630, 1616, 1490 cm−1; 1H NMR (CDCl3, 300 MHz) δ
3.12 (ddd, J = 6.9, 6.6 and 4.2 Hz, 1H), 3.60 (s, 3H), 3.71 (s,
3H), 3.83 (dd, J = 13.2 and 4.2 Hz, 1H), 4.01 (dd, J = 13.2 and
6.9 Hz, 1H), 4.48 (d, J = 6.6 Hz, 1H), 6.71 (d, J = 2.4 Hz, 1H),
7.02 (d, J = 2.4 Hz, 1H), 7.10–7.16 (m, 2H), 7.26–7.39 (m,
3H); 13C NMR (CDCl3, 75 MHz) δ 37.91, 43.16, 45.25,
52.52, 55.92, 108.39, 115.89, 123.63, 124.20, 127.81,
128.44, 129.03, 139.96, 140.72, 156.66, 156.77, 171.42,
183.44; ESIMS m/z 352 [M++H].
Experimental
Compound 4g: 77%; orange solid, m.p. 137–139 ꢀC; IR
(KBr) 1737, 1601, 1473, 1353 cm−1; 1H NMR (CDCl3, 300
MHz) δ 2.09–2.24 (m, 1H), 2.26–2.39 (m, 1H), 3.68–3.86
(m, 2H), 4.14 (dd, J = 7.5 and 4.5 Hz, 1H), 6.97 (t, J = 7.5
Hz, 1H), 7.08–7.18 (m, 3H), 7.26–7.41 (m, 3H), 7.44 (d, J
= 7.5 Hz, 1H); 13C NMR (CDCl3, 75 MHz) δ 29.27, 36.72,
40.60, 115.75, 123.40, 123.55, 124.48, 127.33, 128.20,
128.92, 137.55, 141.92, 147.56, 156.85, 183.87; ESIMS m/
z 264 [M+ + H]. Anal. Calcd. for C17H13NO2: C, 77.55; H,
4.98; N, 5.32. Found: C, 77.51; H, 5.13; N, 5.19.
The starting materials 3a–l were prepared according to the
reported method,5a,5b,7 and the spectroscopic data of the
unknown compounds are reported in Supporting Information.
Typical Procedure for the Synthesis of 4a and 5a. A mix-
ture of 3a (161 mg, 0.5 mmol) and PPA (1.0 g) was heated to
90 ꢀC for 4 h. After the usual aqueous extractive work-up and
column chromatographic purification process (hexanes/
CH2Cl2/Et2O, 10:10:1), compounds 4a (110 mg, 68%) and
5a (22 mg, 15%) were isolated as orange solids. Other com-
pounds were synthesized similarly, and the selected spectro-
scopic data of 4a–d, 4g, 5a, and 5b are as follows:
Compound 5a: 74%; orange solid, m.p. 198–200 ꢀC; IR
(KBr) 1744, 1663, 1619, 1443 cm−1; 1H NMR (CDCl3, 600
MHz) δ 5.13 (d, J = 2.4 Hz, 2H), 7.24 (dd, J = 8.4 and 7.2
Hz, 1H), 7.42 (d, J = 7.2 Hz, 2H), 7.46–7.53 (m, 3H), 7.78
(dd, J = 7.2 and 1.2 Hz, 1H), 8.00 (t, J = 2.4 Hz, 1H), 8.17
(dd, J = 8.4 and 1.2 Hz, 1H); 13C NMR (CDCl3, 150 MHz)
δ 41.91, 116.39, 117.31, 124.07, 126.03, 129.02, 130.27,
130.52, 130.75, 133.75, 135.35, 140.77, 152.02, 156.82,
179.99, 181.16; ESIMS m/z 290 [M+ + H]. Anal. Calcd. for
C18H11NO3: C, 74.73; H, 3.83; N, 4.84. Found: C,
74.95; H, 4.01; N, 4.81.
Compound 4a: 68%; orange solid, m.p. 186–188 ꢀC; IR
(KBr) 1740, 1626, 1603, 1474 cm−1; 1H NMR (CDCl3, 600
MHz) δ 3.14 (ddd, J = 7.2, 6.6 and 4.2 Hz, 1H), 3.61 (s,
3H), 3.89 (dd, J = 13.2 and 4.2 Hz, 1H), 4.03 (dd, J = 13.2
and 7.2 Hz, 1H), 4.52 (d, J = 6.6 Hz, 1H), 7.02 (t, J = 7.2
Hz, 1H), 7.12–7.16 (m, 3H), 7.31 (t, J = 7.2 Hz, 1H),
7.34–7.39 (m, 2H), 7.48 (d, J = 7.2 Hz, 1H); 13C NMR
(CDCl3, 150 MHz) δ 38.05, 43.19, 44.99, 52.51, 115.60,
122.43, 123.80, 123.93, 127.78, 128.45, 129.02, 137.80,
140.07, 146.58, 156.69, 171.42, 183.18; ESIMS m/z
322 [M++H]. Anal. Calcd. for C19H15NO4: C, 71.02; H,
4.71; N, 4.36. Found: C, 70.91; H, 4.93; N, 4.18.
Compound 5b: 14%; orange solid, m.p. 196–198 ꢀC; IR
(KBr) 1737, 1672, 1623, 1490 cm−1; 1H NMR (CDCl3, 300
MHz) δ 2.40 (s, 3H), 5.09 (d, J = 2.7 Hz, 2H), 7.37–7.53
(m, 5H), 7.58 (s, 1H), 7.94 (s, 1H), 7.97 (t, J = 2.7 Hz, 1H);
13C NMR (CDCl3, 75 MHz) δ 20.92, 41.88, 116.48,
117.07, 126.32, 128.99, 130.20, 130.50, 131.54, 133.81,
134.26, 135.03, 140.53, 150.09, 156.91, 180.10, 181.39;
ESIMS m/z 304 [M++H].
Compound 4b: 62%; orange solid, m.p. 182–184 ꢀC; IR
(KBr) 1740, 1624, 1489, 1349 cm−1; 1H NMR (CDCl3, 300
MHz) δ 2.24 (s, 3H), 3.10 (ddd, J = 6.6, 6.3 and 4.2 Hz,
1H), 3.60 (s, 3H), 3.80 (dd, J = 13.5 and 4.2 Hz, 1H), 4.04
(dd, J = 13.5 and 6.6 Hz, 1H), 4.49 (d, J = 6.3 Hz, 1H), 6.96
(s, 1H), 7.09–7.16 (m, 2H), 7.26–7.40 (m, 4H); 13C NMR
(CDCl3, 75 MHz) δ 20.94, 37.78, 43.01, 45.16, 52.51,
115.63, 122.01, 124.36, 127.72, 128.43, 129.00, 133.74,
138.15, 140.33, 144.47, 156.79, 171.50, 183.44; ESIMS m/
z 336 [M+ + H]. Anal. Calcd. for C20H17NO4: C, 71.63; H,
5.11; N, 4.18. Found: C, 71.81; H, 5.30; N, 4.11.
Acknowledgments.
This research was supported by
THE Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by
the Ministry of Education, Science and Technology
(2014R1A1A2053606). Spectroscopic data were obtained
from the Korea Basic Science Institute, Gwangju branch.
Compound 4c: 38%; orange solid, m.p. 214–216 ꢀC; IR
(KBr) 1744, 1621, 1602, 1476 cm−1; 1H NMR (CDCl3, 300
MHz) δ 3.15 (ddd, J = 6.9, 6.6 and 4.2 Hz, 1H), 3.64 (s,
3H), 3.86 (dd, J = 13.5 and 4.2 Hz, 1H), 4.07 (dd, J = 13.5
and 6.9 Hz, 1H), 4.52 (d, J = 6.6 Hz, 1H), 7.10–7.17 (m,
3H), 7.31–7.44 (m, 3H), 7.47 (d, J = 1.8 Hz, 1H); 13C NMR
(CDCl3, 75 MHz) δ 37.94, 42.97, 44.79, 52.65, 116.36,
123.92, 124.11, 128.07, 128.35, 129.21, 129.72, 137.07,
SupportingInformation. Additionalsupportinginformation
is available in the online version of this article.
References
1. For the synthesis and biological activity of pyrrolo[3,2,1-ij]quino-
lines and related compounds, see:(a) M. Layek, M. A. Reddy,
A. V. D. Rao, M. Alvala, M. K. Arunasree, A. Islam,
Bull. Korean Chem. Soc. 2015, Vol. 36, 2773–2776
© 2015 Korean Chemical Society, Seoul & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim